Skip to main content
. 2016 May 28;5(8):1783–1790. doi: 10.1002/cam4.747

Figure 2.

Figure 2

Survival rates among patients with GBM compared on the basis of VWF:Ag levels in plasma.Graph showing Kaplan–Meier estimates of overall survival in GBM patients who underwent gross total resection followed by standard‐of‐care radiation therapy and chemotherapy. The cumulative 1‐year survival in GBM patients with VWF:Ag levels >200 IU/dL (light gray line) was significantly shorter as compared with patients with VWF:Ag levels < 200 IU/dL (dark gray line) (43 vs. 73%; P = 0.009).GBM, glioblastoma; VWF, von Willebrand Factor